FDA approves Briumvi (Ublituximab-Xiiy) for the treatment of relapsing forms of multiple sclerosis (MS) in adults
Briumvi, also known as ublituximab-xiiy, is a medication approved by the FDA for the treatment …
Briumvi, also known as ublituximab-xiiy, is a medication approved by the FDA for the treatment …
For individuals living with the rare and devastating disease Friedreich's ataxia (FA), Skyclary…
Daybue was approved by the U.S. Food and Drug Administration (FDA) on March 13, 2023 for the tr…
Zynyz (retifanlimab-dlwr) received accelerated approval from the FDA On March 22, 2023. The dru…
A newly developed echinocandin antifungal drug called Rezzayo (rezafungin for injection) is pre…
Introduction In the ever-evolving landscape of medical advancements, Joenja has emerged as a…
Qalsody (tofersen), a novel antisense oligonucleotide (ASO) therapy, has emerged as a beacon of…
Introduction Elfabrio (pegunigalsidase alfa-iwxj) is a medication used for the treatment of …
Introduction Miebo (perfluorohexyloctane ophthalmic solution) is a prescription eye drop med…
Introduction Epkinly (epcoritamab) is a novel bispecific CD20-directed CD3 T-cell engager in…
Introduction Xacduro (sulbactam/durlobactam) is a combination antibiotic injection used to t…
Introduction and FDA Approval Ultomiris (ravulizumab-cwvy) is a first-in-class, long-acting …
Agrylin, also known as anagrelide hydrochloride, is a prescription medication used to treat thr…
Translarna (ataluren) is a groundbreaking medication that has emerged as a beacon of hope for i…
Naglazyme, also known by its generic name galsulfase, is a breakthrough medication approved by …